Femasys (FEMY) News Today $0.37 -0.03 (-6.48%) Closing price 09/15/2025 04:00 PM EasternExtended Trading$0.37 +0.00 (+0.63%) As of 04:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FEMY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Femasys expands FemSperm product line with Insemination Prep KitSeptember 11, 2025 | msn.comFemasys Inc. Launches FemSperm Insemination Prep Kit to Enhance Accessibility of Fertility TreatmentsSeptember 11, 2025 | quiverquant.comQFemasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®September 11, 2025 | globenewswire.comFemasys secures MEDSAFE approval for FemBloc Permanent Birth ControlSeptember 9, 2025 | msn.comFemasys Inc. Receives MEDSAFE Approval for FemBloc Permanent Birth Control in New Zealand, Expanding Global Access to Innovative Women's Health SolutionsSeptember 8, 2025 | quiverquant.comQFemasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New ZealandSeptember 8, 2025 | globenewswire.comFemasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control PortfoliosSeptember 2, 2025 | finance.yahoo.comFemasys Announces $8 Million Public OfferingAugust 28, 2025 | msn.comFemasys (FEMY) Falls 27% as Firm to Raise $8-Million from Share SaleAugust 27, 2025 | insidermonkey.comFemasys stock plunges after pricing public offering at steep discountAugust 26, 2025 | za.investing.comFemasys stock falls after pricing capital raise of $8M via securities offeringAugust 26, 2025 | msn.comFemasys Inc. Announces Pricing of Public Offering to Raise Approximately $8 MillionAugust 25, 2025 | quiverquant.comQFemasys Announces Pricing of $8.0 Million Underwritten Public OfferingAugust 25, 2025 | globenewswire.comFemasys Inc.: Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth ControlAugust 20, 2025 | finanznachrichten.deFemasys files to sell 11.43M shares of common stockAugust 20, 2025 | msn.comFemasys Secures UK Regulatory Approval of FemBloc Permanent Birth ControlAugust 20, 2025 | finance.yahoo.comFemasys Gains UK Approval for FemBloc Birth ControlAugust 20, 2025 | tipranks.comFemasys Inc. Advances European Commercialization of FemBloc Permanent Birth Control Following UK Regulatory ApprovalAugust 20, 2025 | quiverquant.comQFemasys Enters European Market with Major Spain OrderAugust 12, 2025 | theglobeandmail.comFemasys Inc.: Femasys Announces Second Quarter Financial Results for 2025August 9, 2025 | finanznachrichten.deFemasys Revenue Jumps 85 Percent in Q2August 8, 2025 | fool.comFemasys Announces Second Quarter Financial Results for 2025August 8, 2025 | globenewswire.comFemasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global ExpansionAugust 6, 2025 | globenewswire.comFemasys Inc. (FEMY) Latest Stock News & Headlines - Yahoo FinanceJuly 11, 2025 | finance.yahoo.comFemasys Enters Purchase Agreement with Alumni CapitalJuly 3, 2025 | tipranks.comFemasys Gains Regulatory Approvals in Australia and New ZealandJuly 1, 2025 | tipranks.comFemasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue DiagnosticJuly 1, 2025 | globenewswire.comFemasys Inc. Receives CE Mark Certification for Revolutionary FemBloc® System for Non-Surgical Permanent Birth Control - NasdaqJune 27, 2025 | nasdaq.comFemasys Gains European Approval for FemBloc SystemJune 26, 2025 | msn.comFemasys Approves Director Elections and Share IncreaseJune 25, 2025 | tipranks.comFemasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth ControlJune 25, 2025 | globenewswire.comFemasys Appoints Kelley Nicholas as Chief Commercial OfficerJune 17, 2025 | tipranks.comFemasys Names New Chief Commercial Officer to Drive Execution and Global GrowthJune 17, 2025 | globenewswire.comFemasys Partners with Carolinas Fertility Institute to Enhance Access to FemaSeed® as First-Line Infertility TreatmentJune 13, 2025 | nasdaq.comThe Analyst Verdict: Femasys In The Eyes Of 6 ExpertsJune 11, 2025 | benzinga.comFemasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 LocationsJune 11, 2025 | globenewswire.comFemasys Announces $4.5 Mln Offering Through Public Sale And Private Placement Of SharesJune 1, 2025 | nasdaq.comFemasys Announces Pricing of Underwritten Public Offering and Concurrent Private Placement with Gross Proceeds of $4.5 MillionMay 30, 2025 | finance.yahoo.comFemasys Stock Slides After Company Prices Public Offering At Discount: Retail’s Planning To Load UpMay 30, 2025 | msn.comFemasys Announces Proposed Public Offering of Common Stock and Concurrent Private PlacementMay 29, 2025 | globenewswire.comFemasys faces potential delisting from NasdaqMay 24, 2025 | uk.investing.com7FEMY : Analyst Expectations For Femasys's FutureMay 9, 2025 | benzinga.comFemasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate UpdateMay 8, 2025 | globenewswire.comFemasys reports FY24 EPS (85c), consensus (81c)March 28, 2025 | markets.businessinsider.comFemasys Reports Wider-Than-Expected Annual Loss, But Retail Continues To Be OptimisticMarch 27, 2025 | msn.comFemasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate UpdateMarch 27, 2025 | globenewswire.comFemasys enters partnership with CNY FertilityMarch 21, 2025 | markets.businessinsider.comFemasys price target raised to $15 from $12 at H.C. WainwrightMarch 20, 2025 | markets.businessinsider.comFemasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 LocationsMarch 19, 2025 | globenewswire.comFemasys secures partnerships for commercialization of FemBloc in SpainMarch 18, 2025 | markets.businessinsider.com Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FEMY Media Mentions By Week FEMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FEMY News Sentiment▼0.740.94▲Average Medical News Sentiment FEMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FEMY Articles This Week▼62▲FEMY Articles Average Week Get the Latest News and Ratings for FEMY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Femasys and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Soleno Therapeutics News Plus Therapeutics News Spectral AI News Milestone Scientific News Fractyl Health News Zynex News Nephros News NeuroOne Medical Technologies News Modular Medical News Titan Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FEMY) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FEMY Stock Alerts